A Phase 2 interventional study of SS-RBX in Urinary Incontinence, Stress, sponsored by Pfizer. Completed at 1 site in Denmark. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2011-06-01.
Sponsored by Pfizer · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Urinary Incontinence, Stress with a site in Denmark — 1 open to participants now, 2 under way, none of them phase 3. Urinary Incontinence, Stress · Denmark.
Among the 15 studies in Urinary Incontinence, Stress with a site in Denmark, this one is the 8th largest by enrollment of the 12 interventional ones that give a count, is the only one that started in 2005, is one of 2 in phase 2, and was the 1st registered.
653 studies on the registry are indexed under Urinary Incontinence, Stress; 122 are open to participants now.
Browse Urinary Incontinence, Stress studies →1 of the 15 studies in Urinary Incontinence, Stress with a site in Denmark is open now. Recruiting first, the newest first:
Ethicon, Inc. · Sites in Denmark, United States, Austria and 4 more countries
Ages 21+ · Women only
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 75 Urinary Incontinence, Stress studies recruiting now, 42 (56%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.
This study: 18 Years to 65 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 3 · Phase 3 3
First in 2005; this study’s year is marked. 1 started in 2005.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 18 is below the median of 68 across 508 interventional studies indexed under Urinary Incontinence, Stress.
Median enrollment 23 across the 12 interventional studies, 198 across the 3 observational. Of the 9 that completed or were terminated, 2 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 15 have an industry lead sponsor. The 8 most frequent:
Pfizer is the lead sponsor of 3,337 studies on the registry; 150 are open to participants now.
Of its 601 completed or terminated interventional studies of FDA-regulated products, 392 (65%) have results posted.
Pfizer has 4 studies filed under Urinary Incontinence, Stress — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Urinary Incontinence, Stress with a site in Denmark, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
To assess the utility of urethral reflectometry in the detection of pharmacologically induced pressure changes in the female urethra.
To assess the effect of [S,S]-Reboxetine on urethral function in women with SUI.
The record gives a start of Dec 2005 and a completion of Jun 2006. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Esreboxetine
Urinary Incontinence, Stress →